Skip to main content

Table 2 Cardiovascular event incidences in the entire cohort of patients, in the dysglycemic patients and in the normoglycemic patients

From: Association between UCP2A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease

Entire cohort of patients

 

AA+AV (n= 383)

VV (n= 176)

  
 

Count

%

Count

%

p

After 2 years

     

Death

21

5.5

12

6.8

0.548

AMI

22

5.7

16

9.1

0.138

Death + AMI

39

10.2

26

14.8

0.113

Revascularization Intervention

28

7.3

21

11.9

0.073

Events

84

21.9

49

27.8

0.098

Dysglycemic patients

 

AA+AV (n= 180)

 

VV (n= 80)

  
 

Count

%

Count

%

p

After 2 years

     

Death

13

7.2

8

10.0

0.514

AMI

7

3.9

9

11.3

0.023

Death + AMI

18

10.0

16

20.0

0.032

Revascularization intervention

11

6.1

13

16.3

0.006

Events

36

20.0

26

32.5

0.020

Normoglycemic patients

 

AA+AV (n= 203)

 

VV (n= 96)

  
 

Count

%

Count

%

p

After 2 years

     

Death

8

3.9

4

4.2

0.765

AMI

15

7.4

7

7.3

0.904

Death + AMI

21

10.3

10

10.4

0.883

Revascularization Intervention

17

8.4

8

8.3

0.969

Events

48

23.6

23

24.0

0.831

  1. AMI: acute myocardial infarction.
  2. Death CV: cardiovascular death.
  3. PCI: percutaneous coronary intervention.
  4. p-values are for log-rank statistics of KM curve comparison of 2 year follow-up period.